Background. The management of pancreaticoduodenal endocrine tumors (PETs) remains
controversial in multiple endocrine neoplasia type 1 (MEN 1). Methods. Twenty-one patients …

Objective: To evaluate the outcome of an aggressive surgical approach for
duodenopancreatic neuroendocrine tumors (PETs) associated with multiple endocrine …

Objective: We sought to develop a comprehensive program for clinical genetic testing in a
large group of extended families with multiple endocrine neoplasia type 1 (MEN 1), with the …

Abstract Introduction Pancreatic endocrine tumors (PETs) occur in at least 50% of patients
with multiple endocrine neoplasia type 1 (MEN1) and are the leading cause of disease …

Purpose This study was made to evaluate long-term results of an aggressive surgical
approach for pancreaticoduodenal neuroendocrine neoplasms (pNENs) in patients with …

Multiple endocrine neoplasia type 1 (MEN1) is an inherited autosomal dominant disease
presenting with pancreatic neuroendocrine tumors (pNETs), parathyroid tumors, or pituitary …

Objective: The aim of this study was to evaluate the results of pancreatic resection in
pancreatic endocrine neoplasias (PENs) in patients affected by multiple endocrine …

Aim: To assess presentation and outcome of pancreaticoduodenal endocrine tumors
(PDETs) in a single center series of multiple endocrine neoplasia type 1 (MEN1) patients …

Doherty GM, Thompson NW (University of Michigan, MI, USA). Multiple endocrine neoplasia
type 1: duodenopancreatic tumours (Minisymposium). J Intern Med 2003; 253: 590–598 …

Early identification of pancreaticoduodenal endocrine tumors (PETs) in multiple endocrine
neoplasia type 1 (MEN-1) is mandatory, because these tumors represent the most common …